MarketPeel
Insider Trading Intelligence
OL

Orbimed Israel Gp Ltd.

ACET
DIRECTOR · ADICET BIO, INC. · CIK 0001569590
FILING MIX · LIFETIME76%/24%
BUYS
25
SELLS
8
TOTAL VALUE
$33.39M
COMPANIES
3
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
2,241,274
AVG SELL PX
$4.06
TRADE KIND
SHOWING 33 / 33
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Orbimed Israel Gp Ltd., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+66.67%+7.84%+1.18%+6.66%+7.32%
14d15+53.33%+9.99%+0.91%+9.08%-1.04%
30d15+46.67%-8.99%+2.76%-11.74%-16.95%
60d15+20.00%-25.11%+2.86%-27.96%-28.60%
90d15+20.00%-34.95%+3.73%-38.68%-33.72%
180d15+33.33%-43.66%+8.33%-51.99%-51.47%
1y15(2 pending)+23.08%-61.03%+18.42%-79.45%-70.94%
2y15(2 pending)+23.08%-73.02%+39.99%-113.01%-112.09%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ACET · 0 shares · as of Apr 8, 2026
02,256,5904,513,1806,769,7699,026,359202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 8 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACET
ADICET BIO, INC.
SALE
40,416$6.52$263.5K0Apr 8, 2026Apr 9, 2026View →
ACET
ADICET BIO, INC.
SALE
32,523$6.29$204.6K0Apr 8, 2026Apr 9, 2026View →
ACET
ADICET BIO, INC.
SALE
2,400$6.38$15.3K32,523Apr 7, 2026Apr 9, 2026View →
ACET
ADICET BIO, INC.
SALE
29,319$6.53$191.5K34,923Apr 7, 2026Apr 9, 2026View →
ACET
ADICET BIO, INC.
PURCHASE
1,500,000$1.00$1.50M9,026,359Oct 8, 2025Oct 10, 2025View →
ACET
ADICET BIO, INC.
PURCHASE
3,500,000$1.00$3.50M4,490,254Oct 8, 2025Oct 10, 2025View →
PHGE
BIOMX INC.
SALE
24,344$0.38$9.3K13,773,653May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
PURCHASE
9,280,408$0.24$2.26M13,797,997May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
SALE
9,280,4080May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
PURCHASE
2,163,5002,163,500Mar 15, 2024Mar 19, 2024View →
PHGE
BIOMX INC.
PURCHASE
4,3274,327Mar 15, 2024Mar 19, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
1,841,100$2.40$4.42M7,526,359Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
242,200$2.40$581.3K990,254Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
1,041,700$2.40$2.50M1,255,985Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
442,000$2.09$923.8K5,685,259Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
125,000$2.09$261.3K1,027,885Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
58,000$2.09$121.2K748,054Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
250,000$2.09$522.5K646,657Jun 27, 2023Jun 29, 2023View →
PHGE
BIOMX INC.
PURCHASE
348,000$0.25$85.3K3,161,489Feb 27, 2023Mar 17, 2023View →
PHGE
BIOMX INC.
PURCHASE
1,789,9591,789,959Feb 27, 2023Mar 17, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
266,376$3.34$889.7K2,311,798Jan 3, 2023Jan 5, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
70,524$4.51$318.1K2,241,274Jan 3, 2023Jan 5, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
214,285$14.00$3.00M242,285Dec 10, 2021Dec 14, 2021View →
PHGE
BIOMX INC.
PURCHASE
500,0002,813,489Jul 28, 2021Jul 30, 2021View →
PHGE
BIOMX INC.
PURCHASE
375,000375,000Jul 28, 2021Jul 30, 2021View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
288,170$17.35$5.00M2,578,174Mar 16, 2021Mar 18, 2021View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
28,81728,817Mar 16, 2021Mar 18, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
420,299$13.00$5.46M5,243,259Feb 12, 2021Feb 18, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
104,050$13.00$1.35M396,657Feb 12, 2021Feb 18, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Sep 17, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
902,885902,855Sep 15, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
292,607292,607Sep 15, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
4,822,9604,822,960Sep 15, 2020Sep 17, 2020View →
Other insiders · ACET
Loading peer insiders…
About this filer
CIK 0001569590
ROLE
Director
PRIMARY
ACET
COMPANIES
3
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001569590DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback